Tuesday, October 21, 2014

Best Building Product Stocks To Own For 2014

Small cap green stocks Eco Depot Inc (OTCMKTS: ECDP), Eco Building Products Inc (OTCMKTS: ECOB) and Profire Energy, Inc (OTCBB: PFIE) has been getting some extra attention lately in various investment newsletters thanks to paid promotions or investor relation campaigns. Of course, there is nothing wrong with properly disclosed promotions and investor relations campaigns, but small cap green stocks tend to be extra volatile when compared with other stocks. So how in greenbacks will these three small cap green stocks produce for investors? Here is a quick reality check:

Eco Depot Inc (OTCMKTS: ECDP) Has the Swiss Army Knife of Water Purifiers

Small cap Eco Depot Inc was formerly an "eco lighting" distributor under new management as the company is in the development stage of transitioning into a manufacturer and distributor of eco friendly consumer brand products. On Friday, Eco Depot Inc fell 6.06% to $0.0930 for a market cap of $4.54 million plus ECDP is up 210% over the past year and down 79.8% over the past five years according to Google Finance.

Top Paper Stocks To Watch For 2015: TrueBlue Inc.(TBI)

TrueBlue, Inc. provides temporary blue-collar staffing services in the United States. It supplies on demand general labor to various industries under the Labor Ready brand; skilled labor to manufacturing and logistics industries under the Spartan Staffing brand; and trades people for commercial, industrial, and residential construction, and building and plant maintenance industries under the CLP Resources brand. The company also provides mechanics and technicians to the aviation maintenance, repair and overhaul, aerospace manufacturing, and assembly industries, as well as to other transportation industries under the Plane Techs brand; and temporary drivers to the transportation and distribution industries under the Centerline brand. It primarily serves small and medium-size businesses. The company was formerly known as Labor Ready, Inc. and changed its name to TrueBlue, Inc. in December 2007. TrueBlue, Inc. was founded in 1985 and is headquartered in Tacoma, Washington.

Advisors' Opinion:
  • [By Jonathan Yates]

    When looking at small cap stocks, it is useful to compare the company with others that have expanded in both share price and size. For those considering investing in the $100 billion staffing industry, the growth of TrueBlue (NYSE: TBI) shows what could be the potential path for Labor SMART (OTCBB: LTNC), as both operate in the $29 billion demand labor sector. Other firms have done well in the staffing industry include Paychex (NASDAQ: PAYX) and ManPower Group (NYSE: MAN).

  • [By Jonathan Yates]

    For those looking to invest in real estate stocks, highly recommended is the Dr. Housing Bubble blog. In a recent posting, the "Dr." pointed out that there was a "Lost Generation" when it came to household income. That has not happened for those investing in staffing industry stocks such as Paychex (NASDAQ: PAYX), Robert Half International (NYSE: RHI), TrueBlue, Inc. (NYSE: TBI), and Labor SMART (OTCBB: LTNC).

Best Building Product Stocks To Own For 2014: Buffalo Wild Wings Inc.(BWLD)

Buffalo Wild Wings, Inc. engages in the ownership, operation, and franchise of restaurants in the United States. The company provides quick casual and casual dining services, as well as serves bottled beers, wines, and liquor. As of July 26, 2011, it had 773 Buffalo Wild Wings locations in 45 states in the United States, as well as in Canada. The company was founded in 1982 and is headquartered in Minneapolis, Minnesota.

Advisors' Opinion:
  • [By Leo Fasciocco]

    Buffalo Wild Wings (BWLD) has annual revenues of $1.3 billion. Its owned and franchised restaurants feature a variety of boldly flavored, made-to-order menu items, including Buffalo, New York-style chicken wings spun in one of their signature sauces.

  • [By Rich Smith]

    This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines focus on the restaurant sector, where one analyst has just downgraded shares of Buffalo Wild Wings (NASDAQ: BWLD  ) , while a second analyst has initiated coverage on... just about everybody else. Let's dig right into the details, beginning with the new coverage.

  • [By Nickey Friedman]

    "Customers have been telling us for some time... 'I don't like to wait for the check,'" said Julia Stewart, CEO of�DineEquity� (NYSE: DIN  ) ,�in an interview on CNBC. DineEquity, the parent company of Applebee's,�and other restaurants like Buffalo Wild Wings (NASDAQ: BWLD  ) and Chili's of Brinker International (NYSE: EAT  ) �are in the process of rolling out pay-at-the-table computer tablets across the nation. While giving consumers a more convenient way to order and pay for their meal is a plus, there is an indirect motivator for the tablets that may lead to higher sales and profits.

Best Building Product Stocks To Own For 2014: First Connecticut Bancorp Inc (FBNK)

First Connecticut Bancorp, Inc. (FCB) is a stock holding company. FCB has been formed in connection with the conversion of First Connecticut Bancorp, Inc. a mutual holding company (MHC), from the mutual to the stock form of organization. As of December 31, 2009, MHC owned all of the outstanding stock of Farmington Bank, a savings bank. The MHC will cease to exist as a result of the conversion, and FCB will own all of the common stock of Farmington Bank. As of December 31, 2009, FCB was not engaged in any business. Farmington Bank is a full-service, community bank with 15 full-service branch offices and four limited service offices, including its main office, located throughout Hartford County, Connecticut.

Farmington Bank provides a diverse range of commercial and consumer services to businesses, individuals and governments across Central Connecticut. Farmington Bank provides a range of banking services to businesses, individuals and governments in Central Connecticut. It also offers a range of residential mortgage loan services. Farmington Bank�� subsidiaries include Farmington Savings Loan Servicing, Inc., Village Investments, Inc., Village Corp., Limited, 28 Main Street Corp., Village Management Corp. and Village Square Holdings Inc.

Farmington Savings Loan Servicing, Inc. operates as Farmington Bank�� passive investment company (PIC). Village Investments, Inc. offers brokerage and investment advisory services through a contract with Infinex Financial Services, a registered broker-dealer. Village Corp., Limited was established to hold certain commercial real estate acquired through foreclosures, deeds in lieu of foreclosure, or other similar means. Village Square Holdings, Inc. holds certain commercial real estate of Farmington Bank, formerly used as Farmington Bank�� operations center prior to its relocation to One Farm Glen Boulevard, Farmington, Connecticut. As of December 31, 2009, 28 Main Street Corp and Village Management Corp were inactive.

Len! ding Activities

Farmington Bank�� primary lending activities consists of the origination of one-to-four family residential real estate loans that are primarily secured by properties located in Hartford County and surrounding counties in Connecticut. During the year ended December 31, 2009, the Bank originated $75.8 million of fixed-rate one-to-four family residential loans. The Bank also offers adjustable-rate mortgage loans for one-to-four family properties, with an interest rate that adjusts annually based on the one-year Constant Maturity Treasury Bill Index, after a one, three, four, five, seven or nine-year initial fixed-rate period. Its adjustable rate mortgage loans generally provide for maximum rate adjustments of 200 basis points per adjustment, with a lifetime maximum adjustment up to 6%, regardless of the initial rate. Its adjustable rate mortgage loans amortize over terms of up to 30 years. During 2009, it originated $49.2 million adjustable rate one-to-four family residential loans and purchased $33 million adjustable rate mortgages.

Farmington Bank originates commercial real estate loans and loans on owner-occupied properties used for a variety of business purposes, including office buildings, industrial and warehouse facilities and retail facilities. As of December 31, 2009, the Bank�� owner-occupied commercial mortgage loans constituted the largest portion of its commercial real estate portfolio. During 2009, commercial mortgage loans totaled $265.5 million and owner-occupied commercial real estate loans totaled $133.3 million of its commercial real estate portfolio.

Farmington Bank offers construction loans, including commercial construction loans and real estate subdivision development loans, to developers, licensed contractors and builders for the construction and development of commercial real estate projects and residential properties. During 2009, the Bank�� loans outstanding, including commercial and residential, totaled $68.7 million! . The Ban! k also originates construction loans to individuals and contractors for the construction and acquisition of personal residences.

Farmington Bank�� commercial business loan portfolio comprises both middle market companies and small businesses located primarily in Connecticut. Farmington Bank�� Resort (Timeshare) Loans include receivables loans, pre-sale loans, inventory loans, acquisition and development loans, and homeowner association loans. During 2009, its timeshare loans totaled $82.8 million. Farmington Bank also offers home equity loans and home equity lines of credit, both of which are secured by owner-occupied one-to-four family residences. At December 31, 2009, home equity loans and equity lines of credit totaled $66.7 million.

Farmington Bank also offers various types of consumer loans, including installment, demand, revolving credit and collateral loans, principally to customers residing in its primary market area with acceptable credit ratings. Its installment and collateral consumer loans generally consist of loans on new and used automobiles, loans collateralized by deposit accounts and unsecured personal loans.

Advisors' Opinion:
  • [By CRWE]

    First Connecticut Bancorp, Inc. (Nasdaq:FBNK) reported that its Board of Directors has voted to pay a cash dividend in the amount of $0.03 per share on June 14, 2012 to all shareholders of record as of June 4, 2012.

Best Building Product Stocks To Own For 2014: Nuveen Preferred and Convertible Income Fund (JPC)

Nuveen Multi-Strategy Income & Growth Fund is a close-ended balanced mutual fund launched by Nuveen Investments Inc. The fund is co-managed by Nuveen Asset Management, Spectrum Asset Management, Tradewinds Global Investors, LLC, and Symphony Asset Management, LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in the stocks of companies operating across diversified sectors. For the fixed income portfolio, it invests in the debt instruments, including high yield debt and senior loans. The fund benchmarks the performance of its portfolio against the Merrill Lynch Preferred Stock Hybrid Securities Index, Lehman Tier 1 Capital Securities Index, Merrill Lynch All U.S. Convertibles Index, and CSFB High Yield index. It was formerly known as Nuveen Preferred and Convertible Income Fund. Nuveen Multi-Strategy Income & Growth Fund was formed on March 26, 2003 and is domiciled in the United States.

Advisors' Opinion:
  • [By Douglas A. McIntyre]

    J.C. Penney (NYSE: JPC) and the KMart and Sears divisions of Sears Holdings (NASDAQ: SHLD) are supposes to be the losers among large U.S. retailers. Their stores are too old, their brands too badly damaged, and their balance sheet too frail for either to do well in the white hot competition for holiday sales. However, their stock prices say otherwise, which means there is some expectation that they will outperform forecasts.

Best Building Product Stocks To Own For 2014: Gilead Sciences Inc.(GILD)

Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.

Advisors' Opinion:
  • [By Ben Levisohn]

    With stocks selling off and biotech giants like Gilead Sciences (GILD) and Biogen Idec (BIIB) falling, Regeneron (REGN) picked a heck of a day to deliver good news.

    Special to The Chronicle

    The biotech giant and its partner Sanofi (SNY) announced that they would start late-stage trials of its eczema treatment after earlier trials showed that it helped reduce symptoms of the skin condition.

    Piper Jaffray’s Edward Tenthoff and team call Regeneron’s dupilumab “a potential blockbuster.” They explain why:

    Last year, Regeneron presented positive Phase IIa data of dupilumab in eosinophilic asthma. With the data presented yesterday in atopic dermatitis, it is becoming evident that targeting IL-4/IL-13 could represent a blockbuster approach for treating allergic diseases. We look for additional responder analysis from the Phase II asthma study of dupilumab in the coming months with Phase IIb data potentially this year. The drug is also being investigated in nasal polyposis.

    We see several milestones for Regeneron in 2H:14 including resumption of U.S. EYLEA sales growth driven by label expansion along with additional data read-outs from the company’s rich pipeline. We reiterate our Overweight rating and $382 price target.

    Shares of Regeneron have dipped 0.1% to $310.64 at 10:05 a.m., besting the the iShares Nasdaq Biotechnology ETF’s (IBB) 1.2% drop to $253.10. Sanofi has fallen 1.3% to $51.57, Gilead Sciences has declined 0.8% to $87.94 and Biogen Idec is off 0.8% at $317.55.

  • [By Charley Blaine]

    The NYSE ARCA Biotechnology Index fell 8.1%. Two exchange-traded funds fell more: The iShares Nasdaq Biotechnology Index ETF (IBB) fell 10.6%. The SPDR S&P Biotech ETF (XBI) dropped 12.9%. That was after rising 16.6% and 25.8%, respectively, in the first two months of the year. Alexion Pharmaceuticals (NASDAQ: ALXN) fell 18 from its intraday high of $185.43 on Feb. 27. Gilead Sciences Inc. (NASDAQ: GILD) was an S&P 500 laggard.

  • [By Ben Levisohn]

    As you can see, since March 1, the iShares MSCI USA Momentum Factor ETF, which holds stocks like Facebook (FB) and Gilead Sciences (GILD), has dropped 3.9%, while the PowerShares S&P 500 High Beta ETF, which counts Nabors Industries (NBR) and First Solar (FSLR) among its largest positions, is down just a touch during the same period.

No comments:

Post a Comment